Skip to main content
Premium Trial:

Request an Annual Quote

Katherine Atkinson

Epic Science has appointed Katherine Atkinson as chief commercial officer, tasked with the development of Epic's global commercial strategy.

Atkinson joins Epic with two decades of life science and healthcare experience, most recently as vice president of business development at Edico Genome. Prior to Edico, Atkinson worked for Illumina, where she oversaw a variety of sales teams. She has also held positions at Fisher Scientific, Thermo Fisher, and Beckman Coulter.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.